Neuroprotective approaches in experimental models of beta-amyloid neurotoxicity: relevance to Alzheimer’s disease
Progress in neuro-psychopharmacology & biological psychiatry
Progress in neuro-psychopharmacology & biological psychiatry
1. beta-Amyloid peptides (A beta s) accumulate abundantly in the Alzheimer’s disease (AD) brain in areas subserving information acquisition and processing, and memory formation. A beta fragments are produced in a process of abnormal proteolytic cleavage of their precursor, the amyloid precursor protein (APP). While conflicting data exist in the literature on the roles of A beta s in the brain, and particularly in AD, recent studies have provided firm experimental evidence for the direct…
Released at: 16.09.2020, written by webmaster_popp
